Show results for
Refine by
Blood Count Analyzer Articles & Analysis
13 news found
Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, underscoring the urgent need for ...
PixCell's HemoScreen is the only 5-part differential CBC analyzer that is both FDA-cleared and CE-marked for point-of-care use. ...
In addition, HemoScreen will help diagnose and treat the aging population, which may have difficulty receiving venous or capillary blood samples." PixCell's HemoScreen is the only 5-part differential CBC analyzer that is both FDA-cleared and CE-marked for point-of-care use. ...
HemoScreen™, developed by PixCell Medical, is the only 5-part differential Complete Blood Count (CBC) analyzer that is both FDA-cleared and CE-marked for point-of-care use. ...
Since its founding in 1968, Sysmex has developed its business by focusing on the hematology field (blood cell count tests), which analyzes the number, type, and size of red and white blood cells as well as platelets. Sysmex has adopted a modular concept since the launch of the XN-Series Automated Hematology ...
The blood count data collected will be analyzed as part of the broader study to better understand risk and resilience factors that may be specific to members of rural communities. The HemoScreen device is FDA cleared to perform the Complete Blood Count (CBC) with intended use at the point of care. HemoScreen is ...
” PixCell Medical’s HemoScreen™ is the first and only FDA-cleared and CE-marked 5-part differential complete blood count (CBC) analyzer that is intended for use at the point of care. The device provides rapid and highly accurate test results for the most frequently ordered blood test. The portable, compact ...
PixCell Medical, innovator of rapid diagnostic solutions at the point-ofcare, today announced a partnership with Triolab, the largest diagnostics distributor in the Nordic and Baltic countries, to be the sole distributor in Sweden of the HemoScreen™, PixCell’s hematology analyzer designed for use at the point of care. “PixCell’s HemoScreen brings ...
The paper, titled A Novel Approach to Hematology Testing at the Point-Of-Care, compares the traditional analysis methods used for blood cell counting to the new imaging flow cytometry method used by the HemoScreen. It shows that imaging is superior to the conventional methods by its ability to better differentiate between cells and being more robust in coping ...
"Almost 30% of Australians live in rural areas making access to many healthcare services difficult. To take a simple blood test, one may have to travel hours to the nearest city or have blood samples flown out to a lab, causing significant delays in receiving results. This technology makes the most common complete blood count ...
With HORIBA Medical’s proven technologies and innovation, the Yumizen H500 is a compact and robust hematology analyzer tailored for all types of laboratories and other clinical settings demanding easy operation and reliable analysis such as routine and satellite laboratories, Emergency Care and Physician’s Offices Based on a unique 3-reagent system with low ...
Production of reagents for hematology analyzer to be newly undertaken Existing plants to be consolidated into this core plant Begun in April of last year, construction of our new plant in Shanghai, China has been now been fully completed. The new plant comprises two buildings. The Phase 1 building was completed in August of last year, after which certain production operations were shifted from ...
Production capacity of hematology reagents is to be doubled Handle expansion in medical services driven by economic growth HORIBA Group's local subsidiary in Brazil, HORIBA ABX Ltda. (1), acquired a 10,000 m2 site(2) on the outskirts of Sao Paolo, Brazil, and will construct a plant there for the manufacture of hematology reagents(3) for hospitals where hematology analyzers are used. The intent ...